J Clin Oncol 41 (18): 3329-3338, 2023.[PUBMED Abstract] Johnston SRD, Harbeck N, Hegg R, et al.: Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR+, HER2-, Node-Positive, High-Risk, Early Breast Cancer (monarchE).
J Clin Oncol 38 (34): 3987-3998, 2020.[PUBMED Abstract] Rastogi P, O'Shaughnessy J, Martin M, et al.: Adjuvant Abemaciclib Plus Endocrine Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative, High-Risk Early Breast Cancer: Results From a Preplanned monarchE Overall Survival Interim Analysis, Including 5-Year Efficacy Outcomes.